Orexigen Therapeutics (OREX)
Add to Watchlists Create an Alert
6.45
-0.03 -0.46%
NASDAQ
May 24, 8:00PM
BATS Real time
Currency in USD
Orexigen Therapeutics Asset Utilization:
0.0245 for Dec. 31, 2012Orexigen Therapeutics Historical Asset Utilization Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 0.0245 |
| Sept. 30, 2012 | 0.0264 |
| June 30, 2012 | 0.0352 |
| March 31, 2012 | 0.0322 |
| Dec. 31, 2011 | 0.0384 |
| Sept. 30, 2011 | 0.0543 |
| June 30, 2011 | 0.0438 |
| March 31, 2011 | 0.0413 |
| Dec. 31, 2010 | 0.0139 |
| Sept. 30, 2010 | 0.0037 |
| June 30, 2010 | 0.001 |
| March 31, 2010 | 0.0013 |
About Asset Utilization
The asset utilization ratio calculates the total revenue earned for every dollar of assets a company owns.
For example, with an asset utilization ratio of 52%, a company earned $.52 for each dollar of assets held by the company. An increasing asset utilization means the company is being more efficient with each dollar of assets it has.
This ratio is frequently used to compare a company's efficiency over time.
Learn More
OREX Asset Utilization Benchmarks
| Companies | |
|---|---|
| Arena Pharmaceuticals | 0.1121 |
| Vivus | 0.0067 |
| Sucampo Pharmaceuticals | 0.5864 |
OREX Asset Utilization Rankings
| Overall |
37th percentile 4771 of 7600 |
| Sector |
25th percentile 487 of 653 in Healthcare |
| Industry |
27th percentile 48 of 66 in Drug Manufacturers - Specialty & Generic |
OREX Asset Utilization Range, Past 5 Years
| Minimum | 0.0007 | Dec 2008 |
| Maximum | 0.0543 | Sep 2011 |
| Average | 0.0170 |